MoneyWorks4Me

Mangalam Drugs & Organics informs about disclosure of related party transactions

11 Jun 2021 Evaluate

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mangalam Drugs & Organics has informed that it has enclosed disclosure of Related Party Transactions, in the format specified in the accounting standards for the year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..